The Current Applications of Nano and Biomaterials in Drug Delivery of Dental Implant
Overview
Authors
Affiliations
Background And Aim: Dental implantology has revolutionized oral rehabilitation, offering a sophisticated solution for restoring missing teeth. Despite advancements, issues like infection, inflammation, and osseointegration persist. Nano and biomaterials, with their unique properties, present promising opportunities for enhancing dental implant therapies by improving drug delivery systems. This review discussed the current applications of nano and biomaterials in drug delivery for dental implants.
Method: A literature review examined recent studies and advancements in nano and biomaterials for drug delivery in dental implantology. Various materials, including nanoparticles, biocompatible polymers, and bioactive coatings, were reviewed for their efficacy in controlled drug release, antimicrobial properties, and promotion of osseointegration.
Results: Nano and biomaterials exhibit considerable potential in improving drug delivery for dental implants. Nanostructured drug carriers demonstrate enhanced therapeutic efficacy, sustained release profiles, and improved biocompatibility. Furthermore, bioactive coatings contribute to better osseointegration and reduced risks of infections.
Conclusion: Integrating current nano and biomaterials in drug delivery for dental implants holds promise for advancing clinical outcomes. Enhanced drug delivery systems can mitigate complications associated with dental implant procedures, offering improved infection control, reduced inflammation, and optimized osseointegration.
Albumin nanoparticles are a promising drug delivery system in dentistry.
Kiarashi M, Yasamineh S Biomed Eng Online. 2024; 23(1):122.
PMID: 39605007 PMC: 11600845. DOI: 10.1186/s12938-024-01318-9.
Baghizadeh S, Tabari K, Abbasi K, Tabatabaei S, Heshmat H J Med Life. 2024; 17(8):776-781.
PMID: 39539429 PMC: 11556523. DOI: 10.25122/jml-2024-0210.
Losiewicz B, Osak P, Gorka-Kulikowska K, Maszybrocka J Materials (Basel). 2024; 17(21).
PMID: 39517442 PMC: 11546479. DOI: 10.3390/ma17215166.
Bassir L, Taravati S, Nouri F, Rahimi S J Med Life. 2024; 17(5):536-542.
PMID: 39144693 PMC: 11320612. DOI: 10.25122/jml-2024-0164.
Interactions Between Oral Microbiota and Cancers in the Aging Community: A Narrative Review.
Aghili S, Rahimi H, Kamali Hakim L, Karami S, Soufdoost R, Oskouei A Cancer Control. 2024; 31:10732748241270553.
PMID: 39092988 PMC: 11378226. DOI: 10.1177/10732748241270553.